Parent-proxy Ratings of Pain Before and After Botulinum Toxin Type A Treatment for Children With Spasticity and Cerebral Palsy
Authors:
- Andrea C. NugentANAndrea C. Nugent
- Frank J. SymonsFSFrank J. Symons
- 1 June 2009
- journal article
- clinical trial
- Published by Wolters Kluwer Health in The Clinical Journal of Pain
- Vol. 25 (5) , 413-417
Abstract
To test the hypothesis that pain would be reduced after botulinum toxin type A (Btx/A) treatment for children with cerebral palsy (CP). Thirty-four pediatric patients with CP (mean age 9 y; 56% male) and their parents were recruited through a regional specialty healthcare center medical clinic and pain research program. A 1-group pretest, posttest treatment design was used on the basis of a standardized parent-proxy report of their child's pain. Overall parent ratings of their child's pain were significantly reduced after Btx/A injection with 62% of parents reporting the absence of pain 1 month after injection (proportion=0.38; 95% confidence interval=0.23-0.55). There were no significant differences for males or females. Although there is considerable evidence that Btx/A is efficacious for the treatment of spasticity associated with CP, there is little direct evidence specific to associated analgesic effects after Btx/A treatment. These preliminary findings indicate that Btx/A treatment for spasticity resulted in significant pain reduction for this patient sample. This was the first study to directly ask parents about their child's pain pre-Btx/A and post-Btx/A treatment. These findings have implications for the management of pain associated with spasticity and CP and suggest further research is warranted.Keywords
This publication has 14 references indexed in Scilit:
- Botulinum Toxin Treatment of Spastic Equinus in Cerebral PalsyAmerican Journal of Physical Medicine & Rehabilitation, 2005
- Pain in Children with Cerebral PalsyJournal of Neuroscience Nursing, 2004
- Treatment of Spasticity With Botulinum ToxinThe Clinical Journal of Pain, 2002
- Management of Spasticity Associated Pain with Botulinum Toxin AJournal of Pain and Symptom Management, 2000
- Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trialDevelopmental Medicine & Child Neurology, 2000
- Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Lower Extremity Spasticity in Cerebral Palsy: A Randomized, Double-Blind, Placebo-Controlled TrialJournal of Pediatric Orthopaedics, 2000
- Botulinum toxin a in the treatment of spasticity: Functional implications and patient selectionArchives of Physical Medicine and Rehabilitation, 1996
- Botulinum toxin A for spasticity, muscle spasms, and rigidityNeurology, 1995
- Treatment of chronic limb spasticity with botulinum toxin A.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Treatment of spasticity with botulinum toxin: A double‐blind studyAnnals of Neurology, 1990